DE69521298T2 - Verfahren zur entdeckung von liganden - Google Patents
Verfahren zur entdeckung von ligandenInfo
- Publication number
- DE69521298T2 DE69521298T2 DE69521298T DE69521298T DE69521298T2 DE 69521298 T2 DE69521298 T2 DE 69521298T2 DE 69521298 T DE69521298 T DE 69521298T DE 69521298 T DE69521298 T DE 69521298T DE 69521298 T2 DE69521298 T2 DE 69521298T2
- Authority
- DE
- Germany
- Prior art keywords
- ligands
- target
- discovering ligands
- discovering
- analogues
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6811—Selection methods for production or design of target specific oligonucleotides or binding molecules
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/0046—Sequential or parallel reactions, e.g. for the synthesis of polypeptides or polynucleotides; Apparatus and devices for combinatorial chemistry or for making molecular arrays
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1048—SELEX
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/04—Libraries containing only organic compounds
- C40B40/06—Libraries containing nucleotides or polynucleotides, or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B50/00—Methods of creating libraries, e.g. combinatorial synthesis
- C40B50/06—Biochemical methods, e.g. using enzymes or whole viable microorganisms
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00351—Means for dispensing and evacuation of reagents
- B01J2219/00427—Means for dispensing and evacuation of reagents using masks
- B01J2219/0043—Means for dispensing and evacuation of reagents using masks for direct application of reagents, e.g. through openings in a shutter
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00497—Features relating to the solid phase supports
- B01J2219/00527—Sheets
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/0059—Sequential processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00596—Solid-phase processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B01J2219/00612—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports the surface being inorganic
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B01J2219/00623—Immobilisation or binding
- B01J2219/00626—Covalent
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B01J2219/00632—Introduction of reactive groups to the surface
- B01J2219/00637—Introduction of reactive groups to the surface by coating it with another layer
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00659—Two-dimensional arrays
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00718—Type of compounds synthesised
- B01J2219/0072—Organic compounds
- B01J2219/00722—Nucleotides
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B60/00—Apparatus specially adapted for use in combinatorial chemistry or with libraries
- C40B60/14—Apparatus specially adapted for use in combinatorial chemistry or with libraries for creating libraries
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
- Y10T436/143333—Saccharide [e.g., DNA, etc.]
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9401833A GB9401833D0 (en) | 1994-02-01 | 1994-02-01 | Method for discovering ligands |
PCT/GB1995/000209 WO1995021265A1 (en) | 1994-02-01 | 1995-02-01 | Methods for discovering ligands |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69521298D1 DE69521298D1 (de) | 2001-07-19 |
DE69521298T2 true DE69521298T2 (de) | 2002-05-08 |
Family
ID=10749622
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69521298T Expired - Fee Related DE69521298T2 (de) | 1994-02-01 | 1995-02-01 | Verfahren zur entdeckung von liganden |
Country Status (7)
Country | Link |
---|---|
US (2) | US6080585A (de) |
EP (1) | EP0742837B1 (de) |
JP (1) | JPH09508791A (de) |
AT (1) | ATE202148T1 (de) |
DE (1) | DE69521298T2 (de) |
GB (1) | GB9401833D0 (de) |
WO (1) | WO1995021265A1 (de) |
Families Citing this family (121)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7375198B2 (en) | 1993-10-26 | 2008-05-20 | Affymetrix, Inc. | Modified nucleic acid probes |
US6156501A (en) * | 1993-10-26 | 2000-12-05 | Affymetrix, Inc. | Arrays of modified nucleic acid probes and methods of use |
NO314334B1 (no) * | 1994-03-07 | 2003-03-10 | Toennesen Svein Olav | Innstillbart feste for skulderstropper på en ryggsekk |
US5663064A (en) * | 1995-01-13 | 1997-09-02 | University Of Vermont | Ribozymes with RNA protein binding site |
US6458530B1 (en) | 1996-04-04 | 2002-10-01 | Affymetrix Inc. | Selecting tag nucleic acids |
ATE366418T1 (de) | 1996-04-25 | 2007-07-15 | Bioarray Solutions Ltd | Licht-regulierte, elektrokinetische zusammensetzung von partikeln an oberflächen |
GB9620749D0 (en) * | 1996-10-04 | 1996-11-20 | Brax Genomics Ltd | Identifying antisense oligonucleotides |
AU744369B2 (en) * | 1997-05-05 | 2002-02-21 | Third Wave Technologies, Inc. | Target-dependent reactions using structure-bridging oligonucleotides |
US20070166741A1 (en) | 1998-12-14 | 2007-07-19 | Somalogic, Incorporated | Multiplexed analyses of test samples |
US6242246B1 (en) * | 1997-12-15 | 2001-06-05 | Somalogic, Inc. | Nucleic acid ligand diagnostic Biochip |
US6087102A (en) | 1998-01-07 | 2000-07-11 | Clontech Laboratories, Inc. | Polymeric arrays and methods for their use in binding assays |
GB2335035B (en) * | 1998-03-03 | 2003-05-28 | Brax Genomics Ltd | Screening for functional antisense agents |
US6979728B2 (en) * | 1998-05-04 | 2005-12-27 | Baylor College Of Medicine | Articles of manufacture and methods for array based analysis of biological molecules |
US7244559B2 (en) * | 1999-09-16 | 2007-07-17 | 454 Life Sciences Corporation | Method of sequencing a nucleic acid |
US7211390B2 (en) * | 1999-09-16 | 2007-05-01 | 454 Life Sciences Corporation | Method of sequencing a nucleic acid |
US7892854B2 (en) | 2000-06-21 | 2011-02-22 | Bioarray Solutions, Ltd. | Multianalyte molecular analysis using application-specific random particle arrays |
US9709559B2 (en) | 2000-06-21 | 2017-07-18 | Bioarray Solutions, Ltd. | Multianalyte molecular analysis using application-specific random particle arrays |
US20020187482A1 (en) * | 2000-09-25 | 2002-12-12 | Zicai Liang | Methods and means of RNA analysis |
AU2002220087A1 (en) * | 2000-11-10 | 2002-05-21 | Stratagene | Gene monitoring and gene identification using cdna arrays |
AU2002255478A1 (en) * | 2001-01-10 | 2002-09-12 | Pe Corporation (Ny) | Kits, such as nucleic acid arrays, comprising a majority of human exons or transcripts, for detecting expression and other uses thereof |
GB0105789D0 (en) * | 2001-03-08 | 2001-04-25 | Expresson Biosystems Ltd | Detecting interactions between oligonucleotides and RNA using fluorescence resonance energy transfer (FRET) |
GB0105790D0 (en) * | 2001-03-08 | 2001-04-25 | Expresson Biosystems Ltd | Detecting binding of mRNA to an oligonnucleotide array using RNA dependent nucleic acid modifying enzymes |
GB0105787D0 (en) * | 2001-03-08 | 2001-04-25 | Expresson Biosystems Ltd | Complex element micro-array and methods of use |
EP2465943A3 (de) | 2001-03-16 | 2012-10-03 | Kalim Mir | Lineare Polymeranzeige |
WO2002090599A1 (en) | 2001-05-09 | 2002-11-14 | Genetic Id, Inc. | Universal microarray system |
EP2070939B1 (de) | 2001-05-25 | 2014-04-02 | Duke University | Modulatoren von pharmakologischen Wirkstoffen |
US20030027133A1 (en) * | 2001-05-31 | 2003-02-06 | Cawse James Norman | Method of improving a mixture experiment |
US7262063B2 (en) | 2001-06-21 | 2007-08-28 | Bio Array Solutions, Ltd. | Directed assembly of functional heterostructures |
WO2003004690A2 (en) * | 2001-07-06 | 2003-01-16 | 454$m(3) CORPORATION | Method for isolation of independent, parallel chemical micro-reactions using a porous filter |
US7297553B2 (en) * | 2002-05-28 | 2007-11-20 | Nanosphere, Inc. | Method for attachment of silylated molecules to glass surfaces |
WO2003006676A2 (en) * | 2001-07-13 | 2003-01-23 | Nanosphere, Inc. | Method for immobilizing molecules onto surfaces |
US20030054396A1 (en) * | 2001-09-07 | 2003-03-20 | Weiner Michael P. | Enzymatic light amplification |
CN100494395C (zh) | 2001-10-15 | 2009-06-03 | 生物芯片技术有限公司 | 通过同时探查和酶介导检测的多态性基因座多重分析 |
US20070264641A1 (en) * | 2001-10-15 | 2007-11-15 | Li Alice X | Multiplexed analysis of polymorphic loci by concurrent interrogation and enzyme-mediated detection |
US20050124022A1 (en) * | 2001-10-30 | 2005-06-09 | Maithreyan Srinivasan | Novel sulfurylase-luciferase fusion proteins and thermostable sulfurylase |
US6956114B2 (en) | 2001-10-30 | 2005-10-18 | '454 Corporation | Sulfurylase-luciferase fusion proteins and thermostable sulfurylase |
US6902921B2 (en) * | 2001-10-30 | 2005-06-07 | 454 Corporation | Sulfurylase-luciferase fusion proteins and thermostable sulfurylase |
EP1481090A4 (de) | 2002-02-15 | 2006-08-09 | Somalogic Inc | Verfahren und reagentien zum nachweis der bindung von zielmolekülen durch nukleinsäureliganden |
US6916621B2 (en) * | 2002-03-27 | 2005-07-12 | Spectral Genomics, Inc. | Methods for array-based comparitive binding assays |
US8048623B1 (en) | 2002-04-24 | 2011-11-01 | The University Of North Carolina At Greensboro | Compositions, products, methods and systems to monitor water and other ecosystems |
US7214492B1 (en) | 2002-04-24 | 2007-05-08 | The University Of North Carolina At Greensboro | Nucleic acid arrays to monitor water and other ecosystems |
US9126165B1 (en) | 2002-04-24 | 2015-09-08 | The University Of North Carolina At Greensboro | Nucleic acid arrays to monitor water and other ecosystems |
US8383342B2 (en) | 2002-04-24 | 2013-02-26 | The University Of North Carolina At Greensboro | Compositions, products, methods and systems to monitor water and other ecosystems |
WO2004047007A1 (en) | 2002-11-15 | 2004-06-03 | Bioarray Solutions, Ltd. | Analysis, secure access to, and transmission of array images |
EP2159285B1 (de) * | 2003-01-29 | 2012-09-26 | 454 Life Sciences Corporation | Verfahren zur Verstärkung und Sequenzierung von Nukleinsäuren |
US7575865B2 (en) * | 2003-01-29 | 2009-08-18 | 454 Life Sciences Corporation | Methods of amplifying and sequencing nucleic acids |
US20050233390A1 (en) * | 2003-04-09 | 2005-10-20 | Allen John W | Device including a proteinaceous factor, a recombinant proteinaceous factor, and a nucleotide sequence encoding the proteinaceous factor |
US7927796B2 (en) | 2003-09-18 | 2011-04-19 | Bioarray Solutions, Ltd. | Number coding for identification of subtypes of coded types of solid phase carriers |
EP1664722B1 (de) | 2003-09-22 | 2011-11-02 | Bioarray Solutions Ltd | Oberflächenimmobilisierter polyelektrolyt mit mehreren, zur kovalenten bindung an biomoleküle fähigen funktionellen gruppen |
EP1692298A4 (de) | 2003-10-28 | 2008-08-13 | Bioarray Solutions Ltd | Optimierung der genexpressionsanalyse unter verwendung immobilisierter fängersonden |
PT1694859E (pt) | 2003-10-29 | 2015-04-13 | Bioarray Solutions Ltd | Análise de ácidos nucleicos multiplexada através de fragmentação de adn de cadeia dupla |
CA2572450A1 (en) | 2004-05-28 | 2005-12-15 | Ambion, Inc. | Methods and compositions involving microrna |
JP3916086B2 (ja) * | 2004-06-29 | 2007-05-16 | ソニー株式会社 | ハイブリダイゼーションなどの相互作用を検出する方法及び検出部、該検出部を備えるバイオアッセイ用基板、ハイブリダイゼーションなどの相互作用を検出する装置、並びに試薬キット |
US7848889B2 (en) | 2004-08-02 | 2010-12-07 | Bioarray Solutions, Ltd. | Automated analysis of multiplexed probe-target interaction patterns: pattern matching and allele identification |
EP2302055B1 (de) | 2004-11-12 | 2014-08-27 | Asuragen, Inc. | Verfahren und Zusammensetzungen, die miRNAs und miRNAa-inhibitorischen Molekülen verbunden sind |
EP2604703B1 (de) | 2005-03-14 | 2017-02-01 | The Board of Trustees of the Leland Stanford Junior University | Verfahren zur Bewertung der Haltbarkeit eines Pfropfs im Körper eines Empfängers fester Organtransplantate |
US8486629B2 (en) | 2005-06-01 | 2013-07-16 | Bioarray Solutions, Ltd. | Creation of functionalized microparticle libraries by oligonucleotide ligation or elongation |
EP1731620A1 (de) | 2005-06-07 | 2006-12-13 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Methode zur Diagnose von Immun-Transplantatstoleranz |
EP2442108B1 (de) | 2006-07-14 | 2016-11-16 | The Regents of The University of California | Krebsbiomarker und Anwendungsverfahren dafür |
EP2145001A2 (de) | 2006-09-19 | 2010-01-20 | Asuragen, Inc. | Von mir-15, mir-26, mir -31,mir -145, mir-147, mir-188, mir-215, mir-216 mir-331, mmu-mir-292-3p regulierte gene und stoffwechselwege als ziele für einen therapeutischen eingriff |
WO2008036765A2 (en) | 2006-09-19 | 2008-03-27 | Asuragen, Inc. | Micrornas differentially expressed in pancreatic diseases and uses thereof |
US7855054B2 (en) | 2007-01-16 | 2010-12-21 | Somalogic, Inc. | Multiplexed analyses of test samples |
US20110136099A1 (en) | 2007-01-16 | 2011-06-09 | Somalogic, Inc. | Multiplexed Analyses of Test Samples |
EP2107911A4 (de) | 2007-01-30 | 2010-09-22 | Pharmacyclics Inc | Verfahren zur bestimmung der krebsresistenz auf histon-deacetylasehemmer |
EP1961825A1 (de) | 2007-02-26 | 2008-08-27 | INSERM (Institut National de la Santé et de la Recherche Medicale) | Verfahren zur Vorhersage des Auftretens von Metastasen bei Brustkrebspatienten |
US8906700B2 (en) | 2007-11-06 | 2014-12-09 | Ambergen, Inc. | Methods and compositions for phototransfer |
WO2009097424A1 (en) | 2008-01-29 | 2009-08-06 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Fstl-1 as a biomarker of inflammation |
US8658379B2 (en) | 2008-01-29 | 2014-02-25 | University of Pittsburgh—of the Commonwealth System of Higher Education | Follistatin-like protein-1 as a biomarker for sepsis |
EP2990487A1 (de) | 2008-05-08 | 2016-03-02 | Asuragen, INC. | Zusammensetzungen und verfahren in zusammenhang mit der mirna-modulation von neovaskularisation oder angiogenese |
US20110201519A1 (en) | 2008-08-18 | 2011-08-18 | Sarwal Minnie M | Methods and Compositions for Determining a Graft Tolerant Phenotype in a Subject |
ES2581774T3 (es) | 2008-08-29 | 2016-09-07 | Janssen Biotech, Inc. | Marcadores y métodos de evaluación y tratamiento de colitis ulcerosa y trastornos relacionados mediante un panel de 20 genes |
US20120052066A1 (en) | 2008-11-07 | 2012-03-01 | Cesar Calderon | Markers and methods for assessing and treating lupus patients susceptible to photoprovocation |
CN104293646A (zh) | 2009-08-22 | 2015-01-21 | 里兰斯坦福初级大学理事会 | 成像并评估胚胎、卵母细胞和干细胞 |
WO2011068829A1 (en) | 2009-12-02 | 2011-06-09 | The Board Of Trustees Of The Leland Stanford Junior University | Biomarkers for determining an allograft tolerant phenotype |
GB0922085D0 (en) | 2009-12-17 | 2010-02-03 | Cambridge Entpr Ltd | Cancer diagnosis and treatment |
EP3214174B1 (de) | 2010-03-04 | 2019-10-16 | InteRNA Technologies B.V. | Mirna-molekül, das über seine quelle definiert ist, und seine diagnostischen und therapeutischen verwendungen bei mit emt assoziierten krankheiten |
WO2011133538A1 (en) | 2010-04-19 | 2011-10-27 | The Procter & Gamble Company | Genetic signatures and gene chips associated with administration of electrically conducted radio frequency current to skin and methods and treatments relating thereto |
BR112012026871A2 (pt) | 2010-04-19 | 2017-06-06 | Procter & Gamble | aplicação combinada de composição tópica e de energia para regular a condição de pele de mamíferos |
EP3508854A1 (de) | 2010-04-27 | 2019-07-10 | The Regents of The University of California | Krebsbiomarker und verfahren zur verwendung davon |
NZ704322A (en) | 2010-07-06 | 2016-07-29 | Interna Technologies Bv | Mirna and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated braf pathway |
WO2012019099A2 (en) | 2010-08-05 | 2012-02-09 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Follistatin-like-protein-1 as a biomarker for inflammatory disorders |
KR20130115250A (ko) | 2010-09-15 | 2013-10-21 | 알막 다이아그노스틱스 리미티드 | 암에 대한 분자적 진단 테스트 |
CA2817882C (en) | 2010-11-17 | 2022-08-23 | Asuragen, Inc. | Mirnas as biomarkers for distinguishing benign from malignant thyroid neoplasms |
EP2474617A1 (de) | 2011-01-11 | 2012-07-11 | InteRNA Technologies BV | MIR zur Behandlung von Neoangiogenese |
WO2012116185A1 (en) | 2011-02-23 | 2012-08-30 | The Board Of Trustees Of The Leland Stanford Junior University | Methods of detecting aneuploidy in human embryos |
WO2012158238A2 (en) | 2011-02-28 | 2012-11-22 | University Of Iowa Research Foundation | Anti-müllerian hormone changes in pregnancy and prediction ofadverse pregnancy outcomes and gender |
US10260097B2 (en) | 2011-06-02 | 2019-04-16 | Almac Diagnostics Limited | Method of using a gene expression profile to determine cancer responsiveness to an anti-angiogenic agent |
US9644241B2 (en) | 2011-09-13 | 2017-05-09 | Interpace Diagnostics, Llc | Methods and compositions involving miR-135B for distinguishing pancreatic cancer from benign pancreatic disease |
WO2013063519A1 (en) | 2011-10-26 | 2013-05-02 | Asuragen, Inc. | Methods and compositions involving mirna expression levels for distinguishing pancreatic cysts |
WO2013063544A1 (en) | 2011-10-27 | 2013-05-02 | Asuragen, Inc. | Mirnas as diagnostic biomarkers to distinguish benign from malignant thyroid tumors |
WO2013087789A1 (en) | 2011-12-13 | 2013-06-20 | Glykos Finland Ltd. | Antibody isoform arrays and methods thereof |
WO2014007623A1 (en) | 2012-07-03 | 2014-01-09 | Interna Technologies B.V. | Diagnostic portfolio and its uses |
WO2014055117A1 (en) | 2012-10-04 | 2014-04-10 | Asuragen, Inc. | Diagnostic mirnas for differential diagnosis of incidental pancreatic cystic lesions |
EP2925885B1 (de) | 2012-12-03 | 2020-02-05 | Almac Diagnostic Services Limited | Molekular-diagnosetest für krebs |
US9868992B2 (en) | 2013-03-15 | 2018-01-16 | Baylor Research Institute | Tissue and blood-based miRNA biomarkers for the diagnosis, prognosis and metastasis-predictive potential in colorectal cancer |
WO2014151551A1 (en) | 2013-03-15 | 2014-09-25 | Baylor Research Institute | Ulcerative colitis (uc)-associated colorectal neoplasia markers |
EP2970909A4 (de) | 2013-03-15 | 2017-02-15 | The University of Chicago | Verfahren und zusammensetzungen in zusammenhang mit t-zell aktivität |
GB201409479D0 (en) | 2014-05-28 | 2014-07-09 | Almac Diagnostics Ltd | Molecular diagnostic test for cancer |
EP3194623B1 (de) | 2014-08-12 | 2022-01-05 | Wayne State University | Systeme und verfahren zur erkennung von stress von stammzellen und verwendungen davon |
WO2016090323A1 (en) | 2014-12-05 | 2016-06-09 | Prelude, Inc. | Dcis recurrence and invasive breast cancer |
GB201512869D0 (en) | 2015-07-21 | 2015-09-02 | Almac Diagnostics Ltd | Gene signature for minute therapies |
CN109073654A (zh) | 2016-04-20 | 2018-12-21 | 苏州爱尔迪思生物科技有限公司 | 用于预测早产的方法和组合物 |
CN109196362A (zh) | 2016-05-17 | 2019-01-11 | 苏州爱尔迪思生物科技有限公司 | 用于提供子痫前期评估的方法和组合物 |
CA3079524A1 (en) | 2017-11-03 | 2019-05-09 | Interna Technologies B.V. | Mirna molecule, equivalent, antagomir, or source thereof for treating and/or diagnosing a condition and/or a disease associated with neuronal deficiency or for neuronal (re)generation |
US11957695B2 (en) | 2018-04-26 | 2024-04-16 | The Broad Institute, Inc. | Methods and compositions targeting glucocorticoid signaling for modulating immune responses |
WO2019213660A2 (en) | 2018-05-04 | 2019-11-07 | The Broad Institute, Inc. | Compositions and methods for modulating cgrp signaling to regulate innate lymphoid cell inflammatory responses |
WO2020036926A1 (en) | 2018-08-17 | 2020-02-20 | Cellecta, Inc. | Multiplex preparation of barcoded gene specific dna fragments |
CA3112792A1 (en) | 2018-09-14 | 2020-03-19 | Prelude Corporation | Method of selection for treatment of subjects at risk of invasive breast cancer |
US20220401460A1 (en) | 2018-10-10 | 2022-12-22 | Dana-Farber Cancer Institute, Inc. | Modulating resistance to bcl-2 inhibitors |
AU2020228047A1 (en) | 2019-02-27 | 2021-09-30 | Madera Therapeutics, LLC | Use of caseinolytic protease P function as a biomarker of drug response to imipridone-like agents |
WO2020186101A1 (en) | 2019-03-12 | 2020-09-17 | The Broad Institute, Inc. | Detection means, compositions and methods for modulating synovial sarcoma cells |
US20220143148A1 (en) | 2019-03-14 | 2022-05-12 | The Broad Institute, Inc. | Compositions and methods for modulating cgrp signaling to regulate intestinal innate lymphoid cells |
US20220142948A1 (en) | 2019-03-18 | 2022-05-12 | The Broad Institute, Inc. | Compositions and methods for modulating metabolic regulators of t cell pathogenicity |
US20220152148A1 (en) | 2019-03-18 | 2022-05-19 | The Broad Institute, Inc. | Modulation of type 2 immunity by targeting clec-2 signaling |
WO2020210521A2 (en) | 2019-04-12 | 2020-10-15 | The Regents Of The University Of California | Compositions and methods for increasing muscle mass and oxidative metabolism |
WO2021030627A1 (en) | 2019-08-13 | 2021-02-18 | The General Hospital Corporation | Methods for predicting outcomes of checkpoint inhibition and treatment thereof |
US11793787B2 (en) | 2019-10-07 | 2023-10-24 | The Broad Institute, Inc. | Methods and compositions for enhancing anti-tumor immunity by targeting steroidogenesis |
US11844800B2 (en) | 2019-10-30 | 2023-12-19 | Massachusetts Institute Of Technology | Methods and compositions for predicting and preventing relapse of acute lymphoblastic leukemia |
US20230044602A1 (en) | 2019-12-20 | 2023-02-09 | EDWARD Via COLLEGE OF OSTEOPATHIC MEDICINE | Cancer signatures, methods of generating cancer signatures, and uses thereof |
WO2022192419A2 (en) | 2021-03-09 | 2022-09-15 | Massachusetts Institute Of Technology | Methods of treating inflammatory bowel disease (ibd) with anti- tnf-blockade |
WO2024028794A1 (en) | 2022-08-02 | 2024-02-08 | Temple Therapeutics BV | Methods for treating endometrial and ovarian hyperproliferative disorders |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4563417A (en) * | 1984-08-31 | 1986-01-07 | Miles Laboratories, Inc. | Nucleic acid hybridization assay employing antibodies to intercalation complexes |
US4921788A (en) * | 1988-04-12 | 1990-05-01 | The Research Foundation Of State University Of New York | Competitive nucleic acid immunoassay for the detection of analytes |
US5700637A (en) * | 1988-05-03 | 1997-12-23 | Isis Innovation Limited | Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays |
US5143854A (en) * | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
US5270163A (en) * | 1990-06-11 | 1993-12-14 | University Research Corporation | Methods for identifying nucleic acid ligands |
DE69128350T2 (de) * | 1990-06-11 | 1998-03-26 | Nexstar Pharmaceuticals Inc | Nukleinsäureliganden |
US5474796A (en) * | 1991-09-04 | 1995-12-12 | Protogene Laboratories, Inc. | Method and apparatus for conducting an array of chemical reactions on a support surface |
US5846708A (en) * | 1991-11-19 | 1998-12-08 | Massachusetts Institiute Of Technology | Optical and electrical methods and apparatus for molecule detection |
US5412087A (en) * | 1992-04-24 | 1995-05-02 | Affymax Technologies N.V. | Spatially-addressable immobilization of oligonucleotides and other biological polymers on surfaces |
DE69233331T3 (de) * | 1991-11-22 | 2007-08-30 | Affymetrix, Inc., Santa Clara | Kombinatorische Strategien zur Polymersynthese |
US5585275A (en) * | 1992-09-02 | 1996-12-17 | Arris Pharmaceutical Corporation | Pilot apparatus for peptide synthesis and screening |
US5635385A (en) * | 1993-09-15 | 1997-06-03 | Temple University-Of The Commonwealth System Of Higher Education | Multi-unit ribozyme inhibition of oncogene gene expression |
US5429807A (en) * | 1993-10-28 | 1995-07-04 | Beckman Instruments, Inc. | Method and apparatus for creating biopolymer arrays on a solid support surface |
-
1994
- 1994-02-01 GB GB9401833A patent/GB9401833D0/en active Pending
-
1995
- 1995-02-01 DE DE69521298T patent/DE69521298T2/de not_active Expired - Fee Related
- 1995-02-01 JP JP7520455A patent/JPH09508791A/ja not_active Ceased
- 1995-02-01 AT AT95907093T patent/ATE202148T1/de not_active IP Right Cessation
- 1995-02-01 US US08/676,140 patent/US6080585A/en not_active Expired - Fee Related
- 1995-02-01 EP EP95907093A patent/EP0742837B1/de not_active Expired - Lifetime
- 1995-02-01 WO PCT/GB1995/000209 patent/WO1995021265A1/en active IP Right Grant
-
2000
- 2000-04-26 US US09/559,402 patent/US20020031766A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US6080585A (en) | 2000-06-27 |
GB9401833D0 (en) | 1994-03-30 |
EP0742837A1 (de) | 1996-11-20 |
DE69521298D1 (de) | 2001-07-19 |
EP0742837B1 (de) | 2001-06-13 |
WO1995021265A1 (en) | 1995-08-10 |
JPH09508791A (ja) | 1997-09-09 |
ATE202148T1 (de) | 2001-06-15 |
US20020031766A1 (en) | 2002-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69521298D1 (de) | Verfahren zur entdeckung von liganden | |
DE50015005D1 (de) | Verfahren zur katalytischen Durchführung von Hydroformylierungen | |
DE69840748D1 (de) | Verfahren zur zubereitung von antisense oligonukleotiden | |
DE69931043D1 (de) | Verfahren zur herstellung von 1,1,1,3,3-pentafluorpropan | |
BR9509494A (pt) | Processo de hidrocianação e composição de catalisador | |
DE69822348D1 (de) | R. b. yun s verfahren zur ausbeutung von tagebaulagerstätten | |
DE69828517D1 (de) | Methode zur dns-isolierung. | |
DE69932609D1 (de) | Verfahren zur herstellung von 1-chloro-1,1,3,3,3-pentafluorpropan | |
DE59106926D1 (de) | Verfahren zur Phosphatierung von Metalloberflächen. | |
DE69824958D1 (de) | Enantioselektive additions-reaktion mit hilfe eines organozink reagenzes | |
DE69509332T2 (de) | Geschoss für die Zerstörung von harten Zielen, die tief vergraben sind | |
DE3672197D1 (de) | Verfahren zur absetzung von in der umwelt bestaendigen organischen verbindungen. | |
ATE270334T1 (de) | Verfahren zur verbesserung der transformationseffizienz. | |
DE58904259D1 (de) | Verfahren zur hydrierung von alfa, beta-ungesaettigten ketonen. | |
DE29713859U1 (de) | Vorrichtung zur Herstellung von Saucen, Teigen o.dgl. | |
DE68919346T2 (de) | Verfahren zur Gasphasenabscheidung von Polysilanen. | |
DE69001877D1 (de) | Verfahren zur beschichtung. | |
DE69030804D1 (de) | Reagenzien zur verbesserung von hybridisierung | |
DE69731112D1 (de) | Verfahren zur synthese von phosphorothioat-oligonukelotiden | |
DE69109868D1 (de) | Verfahren zur bestimmung von dns-sequenzen. | |
DE69811677T2 (de) | Verfahren zur präparation von enantiomer-angereicherten, n-derivatisierten laktamen. | |
DE69942542D1 (de) | Verfahren zur produktion von l-ribose. | |
DE69804416T2 (de) | Verfahren zur Konditionierung von organischen Pigmenten | |
DE19983191T1 (de) | Verfahren zur Steigerung der Effizienz von Geschäften | |
DE59003302D1 (de) | Verfahren zur Herstellung von Schächten. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8332 | No legal effect for de | ||
8370 | Indication related to discontinuation of the patent is to be deleted | ||
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |